Elos Medtech History
Explore over a century of innovation and excellence. Elos Medtech’s history is filled with groundbreaking achievements and strategic expansions that have established us as leaders in medical technology. Discover our history to witness the enduring commitment and milestones that have shaped our mission to transform healthcare.
As the world passed the mid-point of the 20th century, Elos company management recognized that their sophisticated skills and unique experience in precision engineering could be used to meet the overwhelming challenges within global healthcare.
In 1975, we collaborated with Professor Per-Ingvar Brånemark on a project to develop osseointegration and manufactured the first dental implant for Brånemark.
In 1989, the former Aktiebolaget Götene – now called Westergyllen – enters the Nasdaq OMX Stockholm stock exchange in Sweden, to collect funding for growth and acquisitions.
The first important acquisition by Westergyllen is Elos AB, paving the way for increased focus on the healthcare area as contract manufacturer.
To reinforce the expertise and capability in precision manufacturing, Westergyllen acquires the Danish Pinol A/S in 2005 to complement Elos Medtech’s operations. The company becomes one of Europe’s largest players in precision-mechanical components within the medical technology field. Discover more here…
On February 4th, 2008, AB Westergyllen became publicly traded on Nasdaq OMX Nordic under the healthcare category, opening doors to healthcare investors. Discover more…
In May same year, the new strategic intent of the company is redefined with a clear focus on precision applied to medical technology. The company changes name to Elos AB to emphasize this new direction. Discover more…
In 1985, an exciting and expanding cooperation with Novo Nordisk was initiated. Elos signs a new agreement to participate in the creation of a new facility in Tianjin, China for the development and production of mechanical components. Following this agreement, Elos successfully establishes commercial operations in the Chinese market in 2009. Discover more…
To further clarify the focus on precision medical technology, the group embraces the name Elos Medtech with a split into 3 divisions: Dental, Orthopedics and Medical Device. Discover more…
The acquisition of Microplast AB, a Sweden-based company specialized in injection-molding for medical devices, complemented the precision-mechanics expertise in the medical technology business area.
As a completion of the direction started 50 years earlier, the executive board finalized the divestment of the metrology division, fully focusing on medical device and medical technology.
The acquisition of Onyx Medical complemented Elos Medtech’s range of services and strengthened the group’s global footprint – now with facilities in Europe, Asia and the US.
Following the increasing demand for injection-moulded plastic components, Elos Medtech expands the Skara site with 1500m2 to double the production capacity. Discover more…
By doubling the manufacturing space and heavily investing in high-tech equipment for the Memphis site, Elos significantly increased its capacity to support customers in the global orthopedic market. Discover more…
The knack for precision that got us started, now permeates everything we do. In strong collaboration with our customers, we drive progress and advance medical devices within dentistry, orthopedics and life science – helping more people every day, in more places, regain functional abilities that restore their quality of life.
The acquisition of the Klingel Group in 2023 strengthened the group’s global presence while keeping a focus on local service. This union of two exceptional companies makes Elos Medtech one of the top 10 global players in the industry.